The international Testicular Cancer Consortium (TECAC) combined five published genome-wide association studies of testicular germ cell tumor (TGCT; 3,558 cases and 13,970 controls) to identify new susceptibility loci. We conducted a fixed-effects meta-analysis, including, to our knowledge, the first analysis of the X chromosome. Eight new loci mapping to 2q14.2, 3q26.2, 4q35.2, 7q36.3, 10q26.13, 15q21.3, 15q22.31, and Xq28 achieved genome-wide significance (P < 5 × 10 −8 ). Most loci harbor biologically plausible candidate genes. We refined previously reported associations at 9p24.3 and 19p12 by identifying one and three additional independent SNPs, respectively. In aggregate, the 39 independent markers identified to date explain 37% of father-to-son familial risk, 8% of which can be attributed to the 12 new signals reported here. Our findings substantially increase the number of known TGCT susceptibility alleles, move the field closer to a comprehensive understanding of the underlying genetic architecture of TGCT, and provide further clues to the etiology of TGCT.
In Europe and the United States, TGCT is the most common cancer in young men aged 20 to 39 years 1 . The incidence of TGCT is rising and is highest in men of northern European ancestry and lowest in men of African ancestry [1] [2] [3] . Risk factors for TGCT include cryptorchidism, increased adult height, prior diagnosis, and a familial history of TGCT 4-8 ; heritability ranges from 37% to 49% (refs. 9,10) . Despite the multiple lines of evidence demonstrating a considerable genetic component to TGCT risk, linkage and candidate gene approaches to find genes with rare, highly penetrant variants involved in TGCT etiology were unsuccessful 11 .
In contrast, GWAS of TGCT have had remarkable success in identifying susceptibility loci with strong effects. Of the 27 replicated loci, most were discovered using GWAS chip-based microarray platforms [12] [13] [14] [15] [16] [17] [18] , with 13 loci identified after replication on the iCOGs array [19] [20] [21] , and 1 locus was identified as a candidate region 22 . The genes mapping in or near identified susceptibility loci have highlighted several biological themes that are highly likely to be important to TGCT development, including male germ cell maturation and differentiation, KIT-MAPK signaling, DNA damage response, and chromosomal segregation.
We imputed each of five published TGCT GWAS scans 12, 18, 20, 23 and combined the association test statistics for a total of 8,960,654 autosomal SNPs and 249,696 X-chromosome SNPs after excluding those with an INFO (imputation quality) score of <0.3 or a minor allele frequency (MAF) of <0.01. We conducted a fixed-effects meta-analysis for 3,558 cases and 13,970 controls (Online Methods and Supplementary Table 1) . The genomic control factor, λ = 1.037, suggests little systematic inflation from population stratification (Supplementary Fig. 1 ). We identified eight new TGCT susceptibility loci surpassing genome-wide Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor 1 1 4 2 VOLUME 49 | NUMBER 7 | JULY 2017 Nature GeNetics l e t t e r s l e t t e r s significance and an additional four new independent loci in two previously established regions (9p24.3 and 19p12) ( Table 1) . Two of these loci (rs6837349 and rs12912292) showed evidence of effect measure heterogeneity (I 2 > 0.50) across the five sample sets. We also determined the Bayes false discovery probability (BFDP) 24 for these 12 loci using a prior probability of 0.0001 and an odds ratio (OR) of 1. Table 2 ). Two loci, rs61408740 and rs17336718, failed to surpass a BFDP threshold of 0.05, likely because of their low MAFs (0.023 and 0.053, respectively). Prior reports identified 27 independent SNPs in 25 distinct regions and the gr/gr deletion associated with TGCT susceptibility (Fig. 1 ). In our current study, 19 of these SNPs (in 17 loci) reached genome-wide significance ( Table 2 ). Eight previously reported susceptibility markers were not identified in our meta-analysis, which was likely related to limited study power, staged replication of GWAS chip-based array results in published studies, and possible residual population substructure. Considering these limitations and to further place our findings in context, we calculated the BFDP for these 27 loci using a prior probability of 0.10, which assumes that 10% of the previously established loci are true positives (Supplementary Table 2 ). This threshold is more liberal than one that would be used to identify new loci but still may be too conservative for the reidentification of previously reported susceptibility markers. Only one locus among all 27, rs11705932, failed to surpass the BFDP threshold of 0.05. New loci with P ≤ 5 × 10 -8 in this study
(Supplementary
Known loci with P ≤ 5 × 10 -8 in this study
Known loci with P > 5 × 10 -8 in this study Figure 1 All identified SNP markers associated with TGCT susceptibility to date. In the ideograms, red dots and red rs number annotation indicate SNPs identified and described in the current study (P ≤ 5 × 10 −8 ), blue dots and blue rs number annotation represent previously identified SNP markers achieving genomewide significance (P ≤ 5 × 10 −8 ) in the current study, and gray dots and gray rs number annotation represent previously identified SNPs that failed to achieve genomewide significance in this study (P > 5 × 10 −8 ).
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VOLUME 49 | NUMBER 7 | JULY 2017 Nature GeNetics l e t t e r s rs12912292 was the most significant new SNP marker in our study (OR = 1.22; P = 1.38 × 10 −11 ) and marks a 131-kb haplotype block at 15q21.3 ( Table 1 and Supplementary Fig. 2a ). This region contains only a single gene, PRTG, a member of the immunoglobulin superfamily implicated in neurogenesis 25 . PRTG is highly expressed in the thyroid, testes, and uterus (Supplementary Fig. 3a) . No variant in this region is an expression quantitative trait locus (eQTL) in either normal testes or TGCT.
The SNP marker rs60180747 (OR = 1.23; P = 1.10 × 10 −10 ) marks a 261-kb haplotype block at 15q22.31 that contains several genes, including TIPIN (encoding TIMELESS-interacting protein), MAP2K1 (encoding mitogen-activated protein kinase kinase 1), DIS3L (encoding DIS3-like exosome 3′-5′ exoribonuclease), SNAPC5 (encoding small nuclear RNA activating complex, polypeptide 5), ZWILCH (encoding zwilch kinetochore protein), and LCTL (encoding lactase-like) ( Table 1 and Supplementary Fig. 2b) . Several of the encoded proteins, particularly ZWILCH and TIPIN, have high and somewhat tissue-specific expression in testes ( Supplementary Fig. 3b-g ). TIPIN coordinates the DNA replication checkpoint by interacting with replication protein A 26 , and ZWILCH is a kinetochore protein important for proper chromatid alignment during cell division 27 . A missense mutation in ZWILCH, resulting in p.Ser230Gly, lies within the linkage disequilibrium (LD) block (Supplementary Table 3 ). The LD block also contains a single eQTL for RP11-653J6.1, which encodes a long noncoding RNA (lncRNA) with expression highly specific to testes (Supplemental Fig. 3h) . RP11-653J6.1 levels and eQTLs were not assessed in The Cancer Genome Atlas (TCGA) TGCT studies. Further dissection of this signal is needed to pinpoint the likely candidate gene.
The SNP marker rs3755605 (OR = 1.19; P = 3.87 × 10 −9 ) identifies a 213-kb haplotype block containing three genes, GPR160
(encoding G-protein-coupled receptor 160), PHC3 (encoding polyhomeotic homolog 3), and PRKCI (encoding protein kinase C, iota form), at 3q26.2 ( Table 1 and Supplementary Fig. 2c ). Several SNPs across this block are eQTLs for GPR160 (Supplementary Table 3 and Supplementary Fig. 4a) ; the TGCT risk allele is associated with increased expression of GPR160 in both normal testes and TGCT (Supplementary Figs. 5a and 6a) . Several SNPs in the haplotype block are also eQTLs in normal testes for RP11-469J4.3, a lncRNA of unknown function. RP11-469J4.3 is highly expressed in normal testes but lies outside of the haplotype block ( Supplementary  Figs. 3l, 4b, and 5b) . RP11-469J4.3 expression was not measured in the TCGA study.
The SNP marker rs2713206 (OR = 1.26; P = 1.68 × 10 −8 ) lies within a smaller LD region of only 48 kb at 2q14.2. TFCP2L1 (encoding transcription factor CP2-like 1) overlies the entirety of the haplotype block ( Table 1 and Supplementary Fig. 2d) ; SNPs in the region are eQTLs (Supplementary Table 3) , with the risk allele associated with decreased expression of TFCP2L1 in TGCT (Supplementary Fig. 6b) . TFCP2L1 is not expressed in normal adult testes ( Supplementary  Fig. 3m ) but is highly expressed in fetal gonocytes and in germ cell neoplasia in situ, the precursor of TGCT 28, 29 . TFCP2L1 is upregulated in human primordial germ cells during embryogenesis at the time of epigenetic reprogramming 30 but is downregulated during transition from fetal gonocytes into spermatogonia 29 . The SNP marker rs6837349 (OR = 0.84; P = 3.13 × 10 −8 ) is located in an intron of ZFP42 (encoding zinc-finger protein 42) at 4q35.2 and marks a small 11-kb haplotype block containing no other genes ( Table 1 and Supplementary Fig. 2e) . The region has no eQTLs in either normal testes or TGCT, although ZFP42 is expressed exclusively in normal testes (Supplementary Fig. 3n) , specifically in human spermatogonia l e t t e r s and TGCT 29, 31 . Additionally, both ZFP42 and TFCP2L1 are involved in embryonic stem cell pluripotency 30, 32 . The SNP marker rs61408740 (OR = 1.65; P = 1.75 × 10 −8 ) is located in an intron of LHPP (encoding phospholysine phosphohistidine inorganic pyrophosphate phosphatase) at 10q26.13 ( Table 1 and Supplementary Fig. 2f ). Only two SNPs were identified with pairwise r 2 > 0.4 with rs61408740, one in the region of the second gene, FAM175B (Supplementary Table 3) ; neither of these SNPs are eQTLs. LHPP encodes an inorganic diphosphatase that functions in oxidative phosphorylation 33 .
The SNP marker rs11769858 (OR = 0.84; P = 2.38 × 10 −8 ) identifies an 82-kb LD block at 7q36.3 that contains a large portion of NCAPG2 (encoding non-SMC condensin II complex subunit G2) ( Table 1 and Supplementary Fig. 2g ). NCAPG2 encodes a regulatory subunit of the condensin II complex and is highly expressed in testes (Supplementary Fig. 3q ) and plays a role in chromosome assembly and segregation during mitosis 34 .
We also identified a locus marked by SNP rs17336718 (OR = 1.41; P = 3.84 × 10 −8 ) at Xq28 ( Table 1 and Supplementary Fig. 2h ) in an intron of TKTL1 (encoding transketolase-like 1), which is highly expressed in normal testes. The SNP is an eQTL for TKTL1 in TCGA TGCT data (Supplementary Fig. 6c ). TKTL1 converts sedoheptulose to ribose and glyceraldehyde to xylulose, linking the pentose phosphate pathway to the glycolytic pathway. Interestingly, although overexpression of TKTL1 is associated with the Warburg effect and poor prognosis in several cancer types [35] [36] [37] [38] , the TGCT risk allele is associated with lower expression of TKTL1.
At the previously reported TGCT susceptibility locus encompassing DMRT1 on chromosome 9, we identified a third independent signal, rs55873183 (OR = 1.89; P = 2.18 × 10 −23 ) (Table 1, Fig. 2a, and  Supplementary Table 4a) . This intronic SNP marker has r 2 values of 0.03 and 0.06 with the two previously published SNP markers 14, 17 , rs7040024 and rs755383, respectively; it retained genome-wide significance in conditional analysis ( Table 1, Supplementary Table 4b , and Supplementary Fig. 2i ). We also identified three additional independent signals at 19p12: rs58521262, rs34601376, and rs73019876 ( Table 1, Fig. 2b, Supplementary Table 5a,b, and Supplementary Fig. 2j-l) . We identified a SNP, rs2194275 (P = 9.23 × 10 −12 ; OR = 0.76), in moderate LD (r 2 = 0.7) with the previously published rs2195987 (P = 1.21 × 10 −9 ; OR = 0.81), which was more significant in this meta-analysis (Supplementary Table 5b ). The region at 19p12 contains a cluster of Krüppel-associated box zinc-finger protein (KRAB-ZFP) genes 39 . KRAB-ZFPs are highly and differentially expressed in germ cells and are important for the epigenetic reprogramming requisite for normal germ cell development 30 . A number of different GWAS, including one for telomere length 40 , have identified significantly associated SNPs in this region. The 19p12 LD blocks are large: rs58521262 marks a 219-kb block and rs73019876 marks a 184-kb block, and each block contains over 200 relevant SNPs and several genes. The rs73019876 haplotype block is extremely eQTL rich; the expression of both ZNF729 and ZNF676 was affected by eQTLs in normal testes ( Supplementary  Fig. 4c,d) . rs58521262 is an eQTL for ZNF728 and CTD-2291D10.2, which, like ZNF729 (Supplementary Fig. 3t ), are only expressed in normal testes (Supplementary Fig. 3v ). The associated SNPs in the LD block also included two putative missense mutations in ZNF728 (Supplementary Table 3 ) not predicted to be deleterious. Given the multiple independent signals in this region, further study will be required to determine which, if any, are causally involved in TGCT.
Similar to prior reports, several of the loci identified in the current study contain biologically plausible candidate genes, implicating pathways involved in male germ cell development and pluripotency (TFCP2L1 and ZFP42), kinetochore function (ZWILCH), DNA damage response (TIPIN), and metabolic mitochondrial function (TKTL1 and LHPP). We identified eight such loci in new genomic regions and four in previously identified regions. These additional loci bring the cumulative total of independent susceptibility alleles for TGCT to 40. Interestingly, ancestral differences in risk allele frequencies that parallel population-specific TGCT risk also continue to be apparent. Of the 40 identified susceptibility loci, the allele frequencies of all but one differed significantly across continents, according to analysis of data from the AFR (African), AMR (American), ASN (Asian), and EUR (European) populations available in the 1000 Genomes Project 41 , with most comparisons having a P value surpassing that obtained with strict Bonferroni correction (P < 0.00125) (Supplementary Table 6 ). The 12 newly identified susceptibility alleles account for 5.3% of the genetic risk to the brothers of individuals with TGCT and 8.0% of the risk to the sons of individuals with TGCT, increasing the estimates of heritability to 25% and 37% for the risk to brothers and sons, respectively. The newly identified TGCT susceptibility markers continue to demonstrate moderate effects, with ORs that range from 1.17 to 1.89. In comparison with other cancer types, we have accounted for a high proportion of site-specific heritability with fewer loci [42] [43] [44] . 
ONLINE METhOdS
Studies. Detailed characteristics and genotype quality control metrics of the study populations (Denmark, NCI (STEED, FTCS), Norway/Sweden, Penn, UK) have been previously described 12, 15, 18, 19, 23 . Subjects used in the current study are all of European descent, and data from each study were collected and analyzed in accordance with local ethical permissions and informed consent.
Genotype imputation. Genotype imputation was conducted by each center following a similar protocol. SNPs with a call rate of <95%, a Hardy-Weinberg proportion test value of P < 0.000001 or a MAF of <1% were removed prior to imputation. Imputation was conducted using IMPUTE2 software v2.2.2 and v3 of the 1000 Genomes Project Phase 1 data as the reference set. First, the genomic coordinates were lifted over from NCBI human genome build 36 to build 37 using the UCSC liftOver tool. Second, the strand of the inference data was aligned with the 1000 Genomes Project data as informed by allele state comparison or allele frequency matching for A/T and G/C SNPs. A prephasing strategy with SHAPEIT software version 1 was adopted to improve imputation performance. The phased haplotypes from SHAPEIT were imported directly into the IMPUTE2 program. We applied sliding windows of 4 Mb with 250 kb as an overlapping buffer and generated 744 segments for the imputation of autosomes. For the X chromosome, pseudoautosomal region 1 (PAR1), PAR2, and the remaining region, which was split into 37 sections, were imputed separately. We excluded imputed loci with an INFO score of <0.3 or a MAF of <0.01 from further association analysis. Further, we acknowledge the limitations of imputation, including that the accuracy of imputation depends on the LD between markers in the reference panel and the markers to be imputed and that the quality of imputation across scans differs because of imperfect population matching of data sets to the reference panel.
Statistical analysis.
Within each data set, a test for trend was performed for each SNP using SNPTEST software v2.2 or v2.5. Fixed-effects meta-analysis was used to combine individual within-study association estimates from five imputed GWAS scans. Genetic effect heterogeneity across studies was assessed using the I 2 statistic and the P value calculated from Cochran's Q statistic. To refine the association signals of each risk-associated region, we first performed LD pruning using pairwise r 2 > 0.3 and then conducted conditional association analyses to estimate the independent effect of each SNP by simultaneously including, in the same logistic regression model, specified SNPs from the same region that surpassed an unconditional P value of 5 × 10 −8 .
Heritability analysis. To evaluate the familial risk explained by the new loci identified in our study, we estimated the contribution of each SNP using the formula h SNP 2 = β 2 × 2f(1 -f), where β is the log per-allele odds ratio and f is the risk allele frequency 45 . We calculated the proportion of familial risk explained by dividing the summed contribution of all h SNP 2 by the total heritability, which was derived from the log relative risk (RR), where RR = 4 for an affected father and RR = 8 for affected brothers 46 .
In silico bioinformatics analysis. We used HaploReg v4.1 and RegulomeDB v1.1 to explore potential noncoding functional annotation within the ENCODE database in the genomic regions surrounding our SNPs of interest, with particular attention to annotations in induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), as we considered these tissue types to be the best proxies for TGCT. Specifically, we interrogated the LD block of neighboring SNPs in a haplotype block defined by pairwise r 2 >0.4 with the index SNP (Supplementary Table 4) . We also searched the GTEx v6 database to determine whether the haplotype block SNPs were implicated as eQTLs in their sample of 157 normal adult testis tissues with available genotype. Of note, normal testis contains an abundance of stromal cells (i.e., Sertoli and Leydig cells), so it may not be an exact surrogate for germ cells and, in particular, the primordial germ cells from which TGCT is believed to develop. Finally, we assessed our 12 new susceptibility loci for eQTLs among the 128 cases of TGCT with linked genotype data available in TCGA.
For correlation between genotype and expression data in the TCGA TGCT data set, the genotype data were downloaded from NCI's Genomic Data Commons (https://gdc.nci.nih.gov/). Data were converted to PLINK (v1.07) 47 format. Subjects were screened for discordant sex, insufficient genotype call rate (>0.05), and excessive heterozygosity (>±3 s.d. from the mean). SNPs were screened for MAF (>0.01), Hardy-Weinberg equilibrium violations (P < 0.0001), and missingness (>0.01). All quality control steps were performed in PLINK. A total of 5 subjects were removed (all for heterozygosity violations), leaving 145 valid for analysis. The 1000 Genomes Project Phase 3 panel was used as the reference set 41 . Alignment to the reference set and haplotype estimation were performed using SHAPEIT (v2) 48 , and additional SNPs were imputed using IMPUTE2 (ref. 49) . Imputed SNPs with an INFO score <0.4 were discarded. For the 12 SNPs of interest, the risk allele was calculated as the allele with increased odds of TGCT (OR > 1). For each subject, the zygosity with respect to the risk allele was calculated, and genotypes were tabulated.
All available TCGA TGCT data were retrieved from the TCGA Data Coordinating Center and processed through the TCGA pipeline at the TCGA Genome Data Analysis Center at the Institute for Systems Biology. Gene expression matrices were generated for 133 primary tumor samples using available (TCGA level 3) gene expression values from RNA sequencing, expressed as RSEM values 50 . Imputed genotypes for all new SNPs reported in this paper were related to gene expression for the 128 cases with both genotype and gene expression data available. Associations were tested using a linear regression model (using the lm function in R).
Technical validation of imputed SNPs.
To technically validate our imputation findings, we optimized TaqMan assays (Applied Biosystems) for 12 loci according to the standard pipeline at the Cancer Genomics Research Laboratory at the National Cancer Institute (Supplementary Table 7 ). For six loci that failed initial TaqMan assay design, surrogate SNPs in LD with the original SNPs were used. We randomly selected about 1,000 samples previously scanned in one of three GWAS (~300 each from NCI, Penn, and Norway/Sweden) for TaqMan genotyping. For the imputed probabilistic genotypes, a threshold of 0.80 was applied to derive the discrete genotypes. The average concordance rates were 0.98, 0.97, and 0.93 for NCI, Penn, and Norway/Sweden, respectively (Supplementary Table 7 ). Data availability. Individual-level data from the UK GWAS have been deposited in the European Genome-phenome Archive (EGA) under accession EGAS00001001302. Individual-level data have been deposited in the database of Genotypes and Phenotypes (dbGaP) for the University of Pennsylvania (phs001307.v1.p1) and NCI (phs001303.v1.p1). The summary data from the TECAC meta-analysis also have been deposited in dbGaP (phs001349.v1.p1).
